StonvexLoading…
StonvexStonvexStonvexCore line items from RNAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $400.00K | $38.27M | $26.00M | $110.78M |
Operating Income | $-143.41M | $-43.90M | $-86.42M | $14.54M |
Net Income | $-130.30M | $-77.42M | $-219.71M | $35.38M |
EPS (Diluted) | $-5.02 | $-4.49 | $-49.76 | $0.10 |
Total Assets | $296.41M | $435.02M | $305.05M | $165.89M |
Total Liabilities | $422.65M | $441.82M | $444.68M | $72.06M |
Cash & Equivalents | $125.14M | $212.61M | $76.91M | $106.44M |
Free Cash Flow OCF − CapEx | $-79.39M | $-32.77M | $-51.37M | $-32.83M |
Shares Outstanding | 26.01M | 25.77M | 5.40M | 153.04M |